JP2008511574A5 - - Google Patents

Download PDF

Info

Publication number
JP2008511574A5
JP2008511574A5 JP2007528777A JP2007528777A JP2008511574A5 JP 2008511574 A5 JP2008511574 A5 JP 2008511574A5 JP 2007528777 A JP2007528777 A JP 2007528777A JP 2007528777 A JP2007528777 A JP 2007528777A JP 2008511574 A5 JP2008511574 A5 JP 2008511574A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
disorder
methyl
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007528777A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008511574A (ja
Filing date
Publication date
Priority claimed from GB0419315A external-priority patent/GB0419315D0/en
Priority claimed from GB0507386A external-priority patent/GB0507386D0/en
Priority claimed from GB0515010A external-priority patent/GB0515010D0/en
Application filed filed Critical
Priority claimed from PCT/EP2005/009379 external-priority patent/WO2006024517A1/en
Publication of JP2008511574A publication Critical patent/JP2008511574A/ja
Publication of JP2008511574A5 publication Critical patent/JP2008511574A5/ja
Pending legal-status Critical Current

Links

JP2007528777A 2004-08-31 2005-08-29 精神障害の治療のための縮合三環系誘導体 Pending JP2008511574A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0419315A GB0419315D0 (en) 2004-08-31 2004-08-31 Compounds
GB0507386A GB0507386D0 (en) 2005-04-12 2005-04-12 Compounds
GB0515010A GB0515010D0 (en) 2005-07-21 2005-07-21 Compounds
PCT/EP2005/009379 WO2006024517A1 (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives for the treatment of psychotic disorders

Publications (2)

Publication Number Publication Date
JP2008511574A JP2008511574A (ja) 2008-04-17
JP2008511574A5 true JP2008511574A5 (cg-RX-API-DMAC10.html) 2008-06-26

Family

ID=35106764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007528777A Pending JP2008511574A (ja) 2004-08-31 2005-08-29 精神障害の治療のための縮合三環系誘導体

Country Status (17)

Country Link
US (1) US20120022056A1 (cg-RX-API-DMAC10.html)
EP (1) EP1786822A1 (cg-RX-API-DMAC10.html)
JP (1) JP2008511574A (cg-RX-API-DMAC10.html)
KR (1) KR20070057885A (cg-RX-API-DMAC10.html)
CN (1) CN101048414B (cg-RX-API-DMAC10.html)
AR (1) AR053307A1 (cg-RX-API-DMAC10.html)
AU (1) AU2005279278A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0514377A (cg-RX-API-DMAC10.html)
CA (1) CA2578781A1 (cg-RX-API-DMAC10.html)
IL (1) IL181387A (cg-RX-API-DMAC10.html)
MA (1) MA28871B1 (cg-RX-API-DMAC10.html)
MX (1) MX2007002548A (cg-RX-API-DMAC10.html)
NO (1) NO20071326L (cg-RX-API-DMAC10.html)
NZ (1) NZ553506A (cg-RX-API-DMAC10.html)
PE (1) PE20060653A1 (cg-RX-API-DMAC10.html)
TW (1) TW200619221A (cg-RX-API-DMAC10.html)
WO (1) WO2006024517A1 (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316915D0 (en) 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
US7898642B2 (en) 2004-04-14 2011-03-01 Asml Netherlands B.V. Lithographic apparatus and device manufacturing method
WO2007023882A1 (ja) 2005-08-26 2007-03-01 Shionogi & Co., Ltd. Pparアゴニスト活性を有する誘導体
MX2008009475A (es) * 2006-01-23 2008-10-20 Amira Pharmaceuticals Inc Inhibidores triciclicos de 5-lipoxigenasa.
US7501438B2 (en) 2006-07-07 2009-03-10 Forest Laboratories Holdings Limited Pyridoimidazole derivatives
WO2008028859A1 (en) 2006-09-07 2008-03-13 F. Hoffmann-La Roche Ag A process for the manufacture of snac (salcaprozate sodium)
WO2008037681A1 (en) 2006-09-26 2008-04-03 Glaxo Group Limited 5-{2-[4-(2-methyl-5-quinolinyl)-l-piperidinyl] ethyl} quinolinone derivatives as 5ht1a receptor modulators for treating sexual dysfunction, cognition impairement, psychotic disorders, anxiety, depression, etc.
US20080221093A1 (en) * 2007-03-07 2008-09-11 Christian Gege Metalloprotease inhibitors containing a heterocyclic moiety
EP2070933A1 (en) * 2007-12-07 2009-06-17 Laboratorios del Dr. Esteve S.A. Tricyclic triazolic compounds
GB0800840D0 (en) 2008-01-17 2008-02-27 Glaxo Group Ltd Novel salt
CN102015722A (zh) 2008-03-05 2011-04-13 贝林格尔.英格海姆国际有限公司 三环吡啶衍生物、包含此类化合物的药物、它们的用途及其制备方法
WO2010111626A2 (en) * 2009-03-27 2010-09-30 Takeda Pharmaceutical Company Limited Poly (adp-ribose) polymerase (parp) inhibitors
PH12012501661A1 (en) 2010-02-19 2012-10-22 Boehringer Ingelheim Int Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
NZ604035A (en) 2010-06-04 2015-02-27 Albany Molecular Res Inc Glycine transporter-1 inhibitors, methods of making them, and uses thereof
WO2012154731A1 (en) * 2011-05-08 2012-11-15 Vanderbilt University Substituted 1h-pyrrolo[3,2-c]quinolin-4(5h)-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m4
WO2013024130A1 (en) 2011-08-17 2013-02-21 Boehringer Ingelheim International Gmbh Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
EP2792679A1 (en) * 2013-04-19 2014-10-22 Laboratorios Del. Dr. Esteve, S.A. Tricyclic triazolic compounds
CA2912918C (en) * 2013-06-24 2021-07-27 Merck Patent Gmbh Imidazole compounds as modulators of fshr and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9706196A (es) * 1996-08-14 1998-02-28 Pfizer Compuestos triciclicos de piperidinilamino como antagonistas de la sustancia p.
IL124914A (en) * 1997-06-26 2000-10-31 Akzo Nobel Nv Pharmaceutical compositions containing 6-aryl-2,3,5,6-tetrahydroimidazo¬2,1-a¾isoquinoline derivatives and some new such compounds
US6919334B2 (en) * 2002-09-12 2005-07-19 Wyeth Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds

Similar Documents

Publication Publication Date Title
JP2008511574A5 (cg-RX-API-DMAC10.html)
TWI579284B (zh) 咪唑并吡咯啶酮化合物
ES2299888T3 (es) Pirid (2,3-d)pirimidin-2,4-diaminas como inhibidores de pde 2.
JP2017533968A5 (cg-RX-API-DMAC10.html)
JP2014513110A5 (cg-RX-API-DMAC10.html)
JP5615902B2 (ja) イミダゾ[2,1−b][1,3,4]チアジアゾール誘導体
TW444013B (en) Quinoline and quinazoline compounds useful in treating benign prostatic hyperplasia
PE20141557A1 (es) Derivado de pirazoloquinolina
JP2017537949A5 (cg-RX-API-DMAC10.html)
JP2016525076A5 (cg-RX-API-DMAC10.html)
JP2016522232A5 (cg-RX-API-DMAC10.html)
CA2474219A1 (en) Dihydrobenzodiazepin-2-one derivatives iii
JP2015504067A5 (cg-RX-API-DMAC10.html)
JP2017524005A5 (cg-RX-API-DMAC10.html)
JP2019512535A5 (cg-RX-API-DMAC10.html)
RU2350616C2 (ru) Производные пиразоло- и имидазопиримидина
JP2005504080A5 (cg-RX-API-DMAC10.html)
JP2013502431A5 (cg-RX-API-DMAC10.html)
JP2009538852A5 (cg-RX-API-DMAC10.html)
RU2011108024A (ru) 3-азабицикло(3.1.0) гексильные производные в качестве модуляторов метаботропных глутаматных рецепторов
JP2016525075A5 (cg-RX-API-DMAC10.html)
JP2005503345A5 (cg-RX-API-DMAC10.html)
RU2012141706A (ru) Производные оксадиазола и их применение в качестве потенцирующих средств в отношении метаботропных глутаматных рецепторов-842
JP2007512299A5 (cg-RX-API-DMAC10.html)
JP2014526435A5 (cg-RX-API-DMAC10.html)